T E Smithgall

SH2 and SH3 domains: potential targets for anti-cancer drug design.

T. Smithgall, T E Smithgall, 1995, Journal of pharmacological and toxicological methods.

Autophosphorylation of the Fes Tyrosine Kinase

T. Smithgall, K. Peters, Jianze Li, 1996, The Journal of Biological Chemistry.

Solution structure of the human Hck SH3 domain and identification of its ligand binding site.

W. Gmeiner, D. Baldisseri, A. Altieri, 1998, Journal of molecular biology.

The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation

R Nyga, C. Pecquet, V. Penard-Lacronique, 2007, Oncogene.